| Literature DB >> 26528495 |
Mayumi Okada1, Norihisa Ishimura1, Shino Shimura1, Hironobu Mikami1, Eiko Okimoto1, Masahito Aimi1, Goichi Uno1, Naoki Oshima1, Takafumi Yuki1, Shunji Ishihara1, Yoshikazu Kinoshita1.
Abstract
BACKGROUND AND STUDY AIMS: Mallory-Weiss tears (MWTs) are not only a common cause of acute nonvariceal gastrointestinal bleeding but also an iatrogenic adverse event related to endoscopic procedures. However, changes in the clinical characteristics and endoscopic features of MWTs over the past decade have not been reported. The aim of this study was to investigate recent trends in the etiology and endoscopic features of MWTs. PATIENTS AND METHODS: We retrospectively reviewed the medical records of patients with a diagnosis of MWT at our university hospital between August 2003 and September 2013. The information regarding etiology, clinical parameters, endoscopic findings, therapeutic interventions, and outcome was reviewed.Entities:
Year: 2015 PMID: 26528495 PMCID: PMC4612247 DOI: 10.1055/s-0034-1392367
Source DB: PubMed Journal: Endosc Int Open ISSN: 2196-9736
Fig. 1Based on their location, the Mallory-Weiss tears were divided into three groups according to Zeifer’s classification: group I, lacerations only in the esophagus (a); group II, lacerations limited to the stomach (b); group III, lacerations extending from the esophagus across the cardia into the stomach (c).
Fig. 2Definition of circumferential distribution at the esophagogastric junction as shown by endoscopy. Representative endoscopic images for the evaluation of circumferential distribution are shown in an upper gastrointestinal model. The 3-o’clock position (red closed circle) was defined as the right lateral wall of the esophagus aligned with the lesser curvature of the stomach, as indicated by the white lines. a Esophagogastric junction. b Cardia. c Stomach (view looking down). d Stomach (reversed view). A, anterior wall; P, posterior wall; R, right lateral wall; L, left lateral wall.
Etiology of Mallory-Weiss tears.
|
|
| |
| Related to endoscopic procedure | 100 | 52.6 |
| Diagnostic endoscopy | ||
| EGD | 74 | 38.9 |
| ERCP | 4 | 2.1 |
| EUS | 3 | 1.6 |
| Upper DBE | 1 | 0.5 |
| Therapeutic endoscopy | ||
| ESD | 11 | 5.8 |
| ERCP | 5 | 2.6 |
| EMR | 1 | 0.5 |
| EVL | 1 | 0.5 |
| Other causes | 90 | 47.4 |
| Vomiting | 44 | 23.2 |
| Coughing | 1 | 0.5 |
| No preceding history of vomiting | 45 | 23.7 |
| Total | 190 | 100 |
EGD, esophagogastroduodenoscopy; ERCP, endoscopic retrograde cholangiopancreatography; EUS, endoscopic ultrasound; DBE, double-balloon enteroscopy; ESD, endoscopic submucosal dissection; EMR, endoscopic mucosal resection; EVL, endoscopic variceal ligation.
Incidence of Mallory-Weiss tears (MWTs) during endoscopic procedures.
|
|
|
|
|
| EGD | 21 060 | 74 | 0.35 |
| ERCP | 1 873 | 9 | 0.48 |
| EUS | 1 717 | 3 | 0.17 |
| Upper DBE | 40 | 1 | 2.50 |
| ESD | 424 | 11 | 2.59 |
| EMR | 303 | 1 | 0.33 |
| EVL | 132 | 1 | 0.76 |
| Total | 25 549 | 100 | 0.39 |
EGD, esophagogastroduodenoscopy; ERCP, endoscopic retrograde cholangiopancreatography; EUS, endoscopic ultrasound; DBE, double-balloon enteroscopy; ESD, endoscopic submucosal dissection; EMR, endoscopic mucosal resection; EVL, endoscopic variceal ligation.
Conditions associated with Mallory-Weiss tears (MWTs) during endoscopic procedures.
|
|
|
|
|
|
| EGD | 74 | Left | ||
| Screening | 57 | Left | 0 | 10 (3 – 24) |
| Further examination | 17 | Left | 5 | 32.5 (9 – 75) |
| ERCP | 9 | Prone | 9 | 59 (25 – 90) |
| EUS | 3 | Left | 3 | 55 (26 – 63) |
| Upper DBE | 1 | Prone | 1 | 49 |
| ESD | 11 | Left | 11 | 112 (33 – 368) |
| EMR | 1 | Left | 1 | 60 |
| EVL | 1 | Left | 1 | 6 |
| Total | 100 |
EGD, esophagogastroduodenoscopy; ERCP, endoscopic retrograde cholangiopancreatography; EUS, endoscopic ultrasound; DBE, double-balloon enteroscopy; ESD, endoscopic submucosal dissection; EMR, endoscopic mucosal resection; EVL, endoscopic variceal ligation
Characteristics of patients with Mallory-Weiss tears.
|
|
|
| |||
| Age, mean ± SD, y | 69.2 ± 14.7 | 64.0 ± 16.8 | 0.02 | ||
| Male, n (%) | 65 (65.0) | 70 (77.8) | 0.05 | ||
| Regular drinker, n (%) | 26 (26.0) | 29 (32.2) | 0.07 | ||
| Antithrombotic drug, n (%) | 13 (13.0) | 19 (21.1) | 0.65 | ||
| Atrophic gastritis, n (%) | 58 (58.0) | 47 (52.2) | 0.54 | ||
| Hiatal hernia, n (%) | 52 (52.0) | 55 (61.0) | 0.18 | ||
| Multiple lacerations, n (%) | 15 (15.0) | 26 (28.9) | 0.02 | ||
| Length, mean ± SD, cm | 0.9 ± 0.6 | 0.9 ± 0.6 | 0.99 | ||
| Location (esophagus/stomach/both) | 16/67/17 | 13/36/41 | < 0.001 | ||
SD, standard deviation.
Fig. 3Circumferential distribution of Mallory-Weiss tears in patients (a) with and (b) without endoscopic procedures. Mallory-Weiss tears were frequently located in the right lateral wall (2- to 4-o’clock position) at the esophagogastric junction in both groups. A, anterior wall; P, posterior wall; R, right lateral wall; L, left lateral wall.
Characteristics of Mallory-Weiss tears.
|
|
| ||||||
|
|
|
| |||||
| Age, mean ± SD, y | 64.7 ± 16.1 | 69.4 ± 15.5 | 62.9 ± 16.7 | 0.02 | |||
| Male, n (%) | 20 (69.0) | 67 (65.0) | 48 (82.8) | 0.06 | |||
| Atrophic gastritis, n (%) | 13 (44.8) | 58 (56.3) | 34 (58.6) | 0.27 | |||
| Hiatal hernia, n (%) | 14 (48.3) | 57 (55.3) | 36 (62.0) | 0.39 | |||
| Multiple lacerations, n (%) | 4 (13.8) | 15 (14.6) | 22 (37.9) | < 0.01 | |||
| Laceration length, mean ± SD, cm | 0.77 ± 0.53 | 1.0 ± 0.71 | 0.91 ± 0.53 | 0.11 | |||
SD, standard deviation.
Fig. 4Circumferential distribution by location of mucosal lacerations at the esophagogastric junction. a Group I (esophagus). b Group II (stomach). c Group III (esophagus-stomach). Mucosal lacerations were frequently located in the right lateral wall (2- o 4-o’clock position) at the esophagogastric junction in all groups. A, anterior wall; P, posterior wall; R, right lateral wall; L, left lateral wall.
Treatment of Mallory-Weiss tears.
|
|
|
| Conservative management | 130 (68.4) |
| Endoscopic hemostasis | 60 (31.6) |
| Hemoclip placement | 41 (21.6) |
| Hemoclip placement + thrombin spray | 9 (4.7) |
| Thrombin spray | 8 (4.2) |
| Argon plasma coagulation | 1 (0.5) |
| Hemoclip placement + SB tube + saline + epinephrine injection | 1 (0.5) |
| Total | 190 (100) |
SB tube, Sengstaken – Blakemore tube.